EP Patent

EP0444625A1 — Omeprazole compositions designed for administration in Rectum

Assigned to Hanmi Pharmaceutical Industries Co Ltd · Expires 1991-09-04 · 35y expired

What this patent protects

This invention relates to omeprazole compositions designed for administration in rectum, wherein said compositions comprise omeprazole, an active ingredient, a mixture of polyethylene glycol 1,000, 1,510, 4,000, 6,000 or a mixture of adeps solidus and sodium laurylsulfate any one…

USPTO Abstract

This invention relates to omeprazole compositions designed for administration in rectum, wherein said compositions comprise omeprazole, an active ingredient, a mixture of polyethylene glycol 1,000, 1,510, 4,000, 6,000 or a mixture of adeps solidus and sodium laurylsulfate any one of soluble and basic amino acid selected from arginine, lysine or histidine.

Drugs covered by this patent

Patent Metadata

Patent number
EP0444625A1
Jurisdiction
EP
Classification
—
Expires
1991-09-04
Drug substance claim
No
Drug product claim
No
Assignee
Hanmi Pharmaceutical Industries Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.